Apidra Solostar 100IU/ml Injection is used to help individuals with type 1 and type 2 diabetes manage their blood sugar levels. It is a fast-acting form of insulin that helps to decrease blood sugar levels after meals and lowers the risk of getting severe diabetes problems.
Apidra Solostar 100IU/ml Injection is typically given in conjunction with long-acting insulin or other diabetes medications. Your doctor or caregiver will show you how to administer it under the skin correctly. It should be consumed 15 minutes before or within 20 minutes of beginning a dinner. Do not discontinue taking it unless instructed to do so by your doctor.
🛒 How to order this item?
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Show More
Apidra Solostar Pen is a type of insulin that works quickly. Insulin is a naturally occurring substance made by the pancreas that aids in the utilization of glucose (the body's sugar) for energy generation. It is used to manage Diabetes mellitus (a collection of conditions characterized by elevated blood sugar levels in the body) in both children and adults. Apidra Solostar Pen maintains constant sugar management by increasing sugar utilization by muscles and fat cells and reducing sugar production in the liver.
It is unsafe to consume alcohol with Apidra Solostar Pen.
Apidra Solostar 100IU/ml Injection 3 ml can be used during pregnancy. Your insulin dose may need to be changed during pregnancy and after delivery.
Apidra Solostar Pen is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby. Information regarding the use of Apidra Solostar 100IU/ml Injection during breastfeeding is limited. Please consult your doctor.
100 IU/ml of Apidra Solostar 3ml of an injection typically makes people sleepy and impairs their ability to drive. If you have hypoglycemia, it may be harder for you to focus and respond. (low blood sugar).
Apidra Solostar Pen should be used with caution in patients with kidney disease. A dose adjustment of Apidra Solostar Pen may be needed. Please consult your doctor. Regular monitoring of blood glucose levels is recommended for dose adjustment.
Apidra Solostar Pen should be used with caution in patients with liver disease. A dose adjustment of Apidra Solostar Pen may be needed. Please consult your doctor. Frequent and regular monitoring of blood glucose levels is advised.
Apidra Solostar 100IU/ml Injection is a fast-acting insulin that starts working within 10-20 minutes after injecting. It works similarly to the insulin produced by the body. Insulin facilitates the reuptake of glucose in muscle and fat cells and also blocks the release of glucose from the liver.
100 IU/ml Apidra Solostar Injection For the management of diabetes mellitus in both adults and children (over the age of six), 3 ccs of rapid-acting insulin is used. Insulin glulisine is the main component of Apidra Solostar 100IU/ml Injection 3 milliliter. 100 IU/ml Apidra Solostar Injection An equivalent to normal human insulin, 3 ml is a synthetic human insulin derivative. Compared to normal human insulin, insulin glulisine has a quicker start effect and a shorter half-life. A person's blood sugar level will consistently be too high if they have diabetes, which is a permanent disease.
Fast-acting insulin Apidra Solostar 100IU/ml Injection 3 milliliter quickly normalizes blood sugar levels after a meal. After infusion, it usually starts to work within 10–20 minutes, surges after an hour, and continues to work for another 2–4 hours. Apidra Solostar 100IU/ml Injection 3 ml should typically be given in conjunction with intermediate-acting or long-acting insulin preparations due to its brief effect. The action of Apidra Solostar 100IU/ml Injection 3 ml is to ensure quick and reliable sugar management. Fast-acting insulin, such as Apidra Solostar 100IU/ml Injection 3 ml, aids in lowering blood sugar levels following a meal. reduces the chance of developing serious consequences from diabetes.
Controlling glucose metabolism is the main function of insulin and its derivatives, including insulin glulisine. By promoting peripheral glucose uptake, especially in skeletal muscle and fat, and preventing hepatic glucose synthesis, insulin reduces blood glucose levels. Insulin glulisine starts working about two times as quickly as normal human insulin and finishes reducing blood sugar about two hours sooner.
You'll receive instructions from your doctor on how to use 3 milliliters of Apidra Solostar 100IU/ml Injection. It needs to be given between 0 and 15 minutes before or right after meals.
Insulins and insulin analogs, especially insulin glulisine, have the primary role of regulating glucose metabolism. Insulin reduces blood glucose levels by boosting skeletal muscle and adipose glucose uptake while inhibiting hepatic glucose synthesis. Insulin increases protein production while decreasing lipolysis and proteolysis. Insulin Glulisine and regular human insulin have the same glucose-lowering benefits when administered intravenously. After subcutaneous injection, insulin glulisine has a quicker start and a shorter period of an effect than regular human insulin.
When administered intravenously, Insulin Glulisine is a recombinant insulin analog that is equipotent to human insulin (i.e., one unit of Insulin Glulisine has the same glucose-reducing impact as one unit of normal human insulin). Insulin Glulisine has a faster start of the action and a shorter duration of action than normal human insulin when administered subcutaneously.
Insulin Glulisine dose must be tailored to the person. Blood glucose monitoring is important in all insulin-treated individuals. The overall daily insulin needs vary, but it is typically between 0.5 and 1 Unit/kg/day. Insulin requirements can vary as a result of stress, severe sickness, or changes in activity, meal habits, or medications.
When self-injecting insulin, follow these steps:
People who have hypoglycemia or who are allergic to Insulin Glulisine or any of its excipients shouldn't use the medication.
When taking this medicine, patients who have a history of hypersensitivity to Insulin Glulisine or its excipients may suffer localized or generalized hypersensitivity reactions.
Pregnancy Classification C. Although animal reproduction studies have indicated that the medication harms the fetus, and there are no appropriate and well-controlled human trials, the drug's potential advantages may justify its usage in pregnant women despite the dangers.
It is uncertain if insulin glulisine is excreted in human milk by nursing mothers. Because many medications are excreted in human milk, Insulin Glulisine should be given with caution to a breastfeeding mother. Insulin Glulisine can be used during breastfeeding, although diabetic women who are nursing may need to modify their insulin dosage.
Vials and cartridge devices for insulin glulisine should be stored between 2 and 8 degrees Celsius in the refrigerator. Don't expose yourself to the heat. Never store or allow Insulin Glulisine to solidify in a fridge. Throw it out if it has been chilled. Unopened vials/cartridge devices must be used within 28 days if not stored in the refrigerator.
Any unsealed vials, whether chilled or not, must be used within 28 days of opening. The open vial in use can be kept in storage without direct heat or light for up to 28 days if cooling is not feasible, provided that the temperature does not rise above 25°C.
Disclaimer:
ePharma sole intention is to ensure that its consumers get proper
information as musch as possible. Although we do not guarantee the
accuracy and the completeness of the information that provided and
here information is for informational purposes only.
The information contained herein should NOT be used as a substitute
for the advice of a qualified physician. This may not cover
everything about particular health conditions,
lab tests, medicines, all possible side effects, drug interactions,
warnings, alerts, etc. Please consult your healthcare professional
and discuss all your queries related to any disease or medicine. We
intend to support, not replace, the doctor-patient relationship.